2998-7741

Academia Oncology

Academia.edu

Health Score

0 Fair

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 113 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact113 DOIs
2

Add license metadata to 113 records

License metadata tells indexers and readers how each article may be reused.

High impact113 DOIs
3

Add abstracts to 3 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact3 DOIs

DOIs for this ISSN

Showing the top 5 of 112 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 MyPath: the roadmap to implementing patient-centred care (10.20935/acadonco7566)
ORCID License
45.15 7
2 Enigma of AMP-activated protein kinase subunit expression in… (10.20935/acadonco7881)
ORCID License
30.10 3
3 The development and progression of low-grade serous ovarian… (10.20935/acadonco7338)
ORCID License
23.86 2
4 Reciprocal molecular dialogues between ovarian cancer stem c… (10.20935/acadonco7406)
ORCID License
23.86 2
5 Medical and scientific evidence for the cancer attractor (10.20935/acadonco7445)
ORCID License
23.86 2
6 The changing role of surgery in the multidisciplinary manage… (10.20935/acadonco7533)
ORCID License
23.86 2
7 Serous tubal intraepithelial carcinoma—looking into the earl… (10.20935/acadonco7620)
ORCID License
23.86 2
8 Circulating tumor cells in liquid biopsy: progress and chall… (10.20935/acadonco7770)
ORCID License
23.86 2
9 Systematic review of the risk of type 2 diabetes post therap… (10.20935/acadonco6242)
ORCID License
15.05 1
10 The psychological vital signs of incurable cancer: implicati… (10.20935/acadonco6259)
ORCID License
15.05 1
11 Ovarian clear cell carcinoma: research progress in oncogenes… (10.20935/acadonco7317)
ORCID License
15.05 1
12 Radiation therapy fractionation in the modern era of head an… (10.20935/acadonco7352)
ORCID License
15.05 1
13 Cancer diagnosis after emergency presentation: impact of dem… (10.20935/acadonco7422)
ORCID License
15.05 1
14 Circulating tumor DNA in head and neck squamous cell carcino… (10.20935/acadonco7456)
ORCID License
15.05 1
15 ‘I don’t think I really realised how different the ‘new norm… (10.20935/acadonco7465)
ORCID License
15.05 1
16 Clonal evolution and molecular mechanisms of ovarian cancer:… (10.20935/acadonco7484)
ORCID License
15.05 1
17 Ovarian cancer screening: where do we stand now? (10.20935/acadonco7488)
ORCID License
15.05 1
18 Redefining the role of anthracyclines in early breast cancer… (10.20935/acadonco7516)
ORCID License
15.05 1
19 The discovery of small-molecule inhibitors of cFLIP that sen… (10.20935/acadonco7680)
ORCID License
15.05 1
20 Effect of perceived social support on cancer patients: a nar… (10.20935/acadonco7681)
ORCID License
15.05 1
21 Genomic evolution of ovarian endometrioid and clear-cell car… (10.20935/acadonco7686)
ORCID License
15.05 1
22 Emerging evidence links cannabis use to increased risk of br… (10.20935/acadonco7758)
ORCID License
15.05 1
23 Unraveling neutrophil diversity in ovarian cancer: bridging… (10.20935/acadonco7808)
ORCID License
15.05 1
24 Advancing head and neck cancer surgery through transoral rob… (10.20935/acadonco7811)
ORCID License
15.05 1
25 HSP90 inhibition reverses resistance to TRAIL-induced apopto… (10.20935/acadonco7845)
ORCID License
15.05 1
26 Risk-adapted durations of hormone therapy combined with radi… (10.20935/acadonco8038)
ORCID License
15.05 1
27 Are H&E-based computational models transforming molecula… (10.20935/acadonco8050)
ORCID License
15.05 1
28 The experience and needs of myeloma patients: exploring race… (10.20935/acadonco6185)
ORCID License
0.00 0
29 Academia Oncology: a forum for interdisciplinary cancer rese… (10.20935/acadonco6186)
Abstract References ORCID License
0.00 0
30 Implications of risk-reducing bilateral mastectomy among bre… (10.20935/acadonco6247)
ORCID License
0.00 0
31 The NCI-NIEHS new Cohorts for Environmental Exposures and Ca… (10.20935/acadonco7271)
ORCID License
0.00 0
32 Effects of prenatal chemical exposures on age at menarche: a… (10.20935/acadonco7293)
ORCID License
0.00 0
33 Study of signaling routes in adenocarcinoma in situ and aden… (10.20935/acadonco7299)
ORCID License
0.00 0
34 Downregulation of UGT2B15 and UGT2B17 contributes to acquire… (10.20935/acadonco7321)
ORCID License
0.00 0
35 Correlation of endometrial tumor DNA mismatch repair status… (10.20935/acadonco7330)
ORCID License
0.00 0
36 The changing role of surgery in head and neck oncology (10.20935/acadonco7372)
Abstract References ORCID License
0.00 0
37 Viewpoint: prognostic markers can personalize adjuvant thera… (10.20935/acadonco7393)
ORCID License
0.00 0
38 The evolutionary progression of cancers (10.20935/acadonco7415)
ORCID License
0.00 0
39 Case study: world’s largest renal myopericytoma—management a… (10.20935/acadonco7420)
ORCID License
0.00 0
40 New therapeutic targets in the management of advanced gastri… (10.20935/acadonco7447)
ORCID License
0.00 0
41 Management of early-stage breast cancer (EBC) in older adult… (10.20935/acadonco7478)
ORCID License
0.00 0
42 Strategies to enhance the racial and ethnic diversity of bre… (10.20935/acadonco7480)
ORCID License
0.00 0
43 Recent clinical and molecular findings in low-grade serous o… (10.20935/acadonco7482)
ORCID License
0.00 0
44 Caregivers’ role in the improvement of clinical outcome in p… (10.20935/acadonco7507)
ORCID License
0.00 0
45 Analytical software for visual and quantitative comparison o… (10.20935/acadonco7529)
ORCID License
0.00 0
46 Biliary tract cancers: a descriptive study in the population… (10.20935/acadonco7553)
ORCID License
0.00 0
47 Early neutrophil-to-lymphocyte ratio changes may act as pred… (10.20935/acadonco7574)
ORCID License
0.00 0
48 The use of machine learning to predict cervical cancer progr… (10.20935/acadonco7707)
ORCID License
0.00 0
49 Mechanistic insights into the anticancer potential of Potent… (10.20935/acadonco7711)
ORCID License
0.00 0
50 Targeted therapy combinations with ipatasertib in multi-cell… (10.20935/acadonco7726)
ORCID License
0.00 0